Shurin MR - Search Results

1

Tumor-derived factors modulating dendritic cell function.

Zong J, Keskinov AA, Shurin GV, Shurin MR. Zong J, et al. Among authors: shurin gv, shurin mr. Cancer Immunol Immunother. 2016 Jul;65(7):821-33. doi: 10.1007/s00262-016-1820-y. Epub 2016 Mar 16. Cancer Immunol Immunother. 2016. PMID: 26984847 Free PMC article. Review.

2

Dendritic cells presenting tumor antigen.

Shurin MR. Shurin MR. Cancer Immunol Immunother. 1996 Nov;43(3):158-64. doi: 10.1007/s002620050317. Cancer Immunol Immunother. 1996. PMID: 9001569 Review.

3

FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma.

Esche C, Subbotin VM, Maliszewski C, Lotze MT, Shurin MR. Esche C, et al. Among authors: shurin mr. Cancer Res. 1998 Feb 1;58(3):380-3. Cancer Res. 1998. PMID: 9458075

4

Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms.

Okada H, Tahara H, Shurin MR, Attanucci J, Giezeman-Smits KM, Fellows WK, Lotze MT, Chambers WH, Bozik ME. Okada H, et al. Among authors: shurin mr. Int J Cancer. 1998 Oct 5;78(2):196-201. doi: 10.1002/(sici)1097-0215(19981005)78:2<196::aid-ijc13>3.0.co;2-9. Int J Cancer. 1998. PMID: 9754652 Free article.

5

CD154 inhibits tumor-induced apoptosis in dendritic cells and tumor growth.

Esche C, Gambotto A, Satoh Y, Gerein V, Robbins PD, Watkins SC, Lotze MT, Shurin MR. Esche C, et al. Among authors: shurin mr. Eur J Immunol. 1999 Jul;29(7):2148-55. doi: 10.1002/(SICI)1521-4141(199907)29:07<2148::AID-IMMU2148>3.0.CO;2-F. Eur J Immunol. 1999. PMID: 10427977 Free article.

6

Tumor's other immune targets: dendritic cells.

Esche C, Lokshin A, Shurin GV, Gastman BR, Rabinowich H, Watkins SC, Lotze MT, Shurin MR. Esche C, et al. Among authors: shurin gv, shurin mr. J Leukoc Biol. 1999 Aug;66(2):336-44. doi: 10.1002/jlb.66.2.336. J Leukoc Biol. 1999. PMID: 10449178

7

Interleukin-2: developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunity.

Lotze MT, Shurin M, Esche C, Tahara H, Storkus W, Kirkwood JM, Whiteside TL, Elder EM, Okada H, Robbins P. Lotze MT, et al. Cancer J Sci Am. 2000 Feb;6 Suppl 1:S61-6. Cancer J Sci Am. 2000. PMID: 10685662 Review.

8

Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice.

Pirtskhalaishvili G, Shurin GV, Gambotto A, Esche C, Wahl M, Yurkovetsky ZR, Robbins PD, Shurin MR. Pirtskhalaishvili G, et al. Among authors: shurin gv, shurin mr. J Immunol. 2000 Aug 15;165(4):1956-64. doi: 10.4049/jimmunol.165.4.1956. J Immunol. 2000. PMID: 10925278

9

Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins.

Pirtskhalaishvili G, Shurin GV, Esche C, Cai Q, Salup RR, Bykovskaia SN, Lotze MT, Shurin MR. Pirtskhalaishvili G, et al. Among authors: shurin gv, shurin mr. Br J Cancer. 2000 Aug;83(4):506-13. doi: 10.1054/bjoc.2000.1289. Br J Cancer. 2000. PMID: 10945499 Free PMC article.

10

Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells.

Aalamian M, Pirtskhalaishvili G, Nunez A, Esche C, Shurin GV, Huland E, Huland H, Shurin MR. Aalamian M, et al. Among authors: shurin gv, shurin mr. Prostate. 2001 Jan 1;46(1):68-75. doi: 10.1002/1097-0045(200101)46:1<68::aid-pros1010>3.0.co;2-2. Prostate. 2001. PMID: 11170134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

179 results

Search Page